THE EFFECT OF HERBESSER ON NO-REFLOW AND IN THE ROLE OF IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PCI

被引：0
|
作者：
Zhang-Qiang, C. [1 ]
Lang, H. [1 ]
Min, Y. [2 ]
机构：
[1] Jiangxi Prov Peoples Hosp, Dept Cardiol, Nanchang 330006, Peoples R China
[2] Beijing Fu Wai Hosp, Beijing 100037, Peoples R China
来源：
HEART | 2015年 / 101卷
关键词：
D O I：
10.1136/heartjnl-2014-307109.77
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ASSA140801
引用
收藏
页码：A30 / A30
页数：1
相关论文
共 50 条
  • [41] Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction
    Tartan, Zeynep
    Ozer, Nihat
    Uyarel, Huseyin
    Akgul, Ozgur
    Gul, Mehmet
    Cetin, Mustafa
    Kasikcioglu, Hulya
    Cam, Nese
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (06) : 441 - 447
  • [42] Microrna-208a: A Marker of No-Reflow in STEMI Patients Undergoing Primary Percutaneuos Coronary Intervention
    Salama, Abou Bakr M.
    Khalil, Wael A.
    Al-Zaky, Manar M.
    Abdallah, Somia H.
    Kandil, Nader T.
    Abdelsabour, Ahmed
    Shaker, Ahmed M.
    Hasanein, Mesbah T.
    Luciani, Giovanni B.
    Azzazy, Hassan
    CIRCULATION RESEARCH, 2020, 127
  • [43] DETERMINANTS AND IMPLICATIONS OF NO-REFLOW PHENOMENON SHORTLY AFTER CORONARY REFLOW IN PATIENTS WITH ACUTE ANTERIOR MYOCARDIAL-INFARCTION
    ITO, H
    ABURAYA, M
    OH, H
    WATADA, H
    HIGASHINO, Y
    MINAMINO, T
    CIRCULATION, 1993, 88 (04) : 160 - 160
  • [44] Predictors of no-reflow in patients undergoing primary percutaneous coronary intervention. Thrombus aspiration was protective
    Hassan, Ayman K. M.
    Mohamed, Hamdy Shams Eddin
    Mohamed, Ahmed Mahdy
    Ahmed, Tarek A. N.
    Kishk, Yehia Taha
    EGYPTIAN HEART JOURNAL, 2018, 70 (04): : 421 - 426
  • [45] Is bivalirudin monotherapy sufficient for diabetic patients with acute coronary syndrome (ACS) undergoing PCI?
    Feit, Frederick
    Manoukian, Steven V.
    Ebrahimi, Ramin
    Pollack, Charles V.
    Ohman, E. Magnus
    Attubato, Michael J.
    Mehran, Roxana
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 14M - 14M
  • [46] The effect of hsCRP on TyG index-associated cardiovascular risk in patients with acute coronary syndrome undergoing PCI
    Ma, Xiaoteng
    Chu, Huijun
    Sun, Yan
    Cheng, Yujing
    Zhang, Dai
    Zhou, Yujie
    Liu, Xiaoli
    Wang, Zhijian
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [47] Possible Role of Platelet Reactivity in No-reflow Phenomenon in Patients With Acute Myocardial Infarction
    Aurigemma, Cristina
    Scalone, Giancarla
    Barone, Lucy
    Di Monaco, Antonio
    Lamendola, Priscilla
    Sestito, Alfonso
    Lanza, Gaetano A.
    Crea, Filippo
    CIRCULATION, 2009, 120 (18) : S1120 - S1121
  • [48] Effect of Chronic Pretreatment of Angiotensin-converting Receptor Blocker on No-Reflow Phenomenon in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Hu, Tao
    Wang, Hai-Chang
    Wang, Ru-Tao
    Lv, An-Lin
    Luan, Rong-Hua
    Li, Cheng-Xiang
    Cheng, He-Xiang
    Xia, Cheng-Hai
    Tao, Ling
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (07): : 10B - 10B
  • [49] The Relationship Between High-Dose Atorvastatin Loading and the No-Reflow Phenomenon in STEMI Patients Undergoing Primary PCI
    Hennawy, Bassam S.
    Mohammed, Amr M.
    Fouad, Khaled A.
    IRANIAN HEART JOURNAL, 2025, 26 (01): : 54 - 66
  • [50] Treating Acute "No-Reflow" with Intracoronary Adenosine in 4 Patients during Percutaneous Coronary Intervention
    Forman, Mervyn B.
    Hou, Dongming
    Jackson, Edwin K.
    TEXAS HEART INSTITUTE JOURNAL, 2008, 35 (04): : 439 - 446
12345